Stamford, CT -- (SBWIRE) -- 01/21/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: DARA Biosciences Inc (NASDAQ:DARA), Castle Brands Inc (NYSEMKT:ROX), DURECT Corporation (NASDAQ:DRRX), CEL-SCI Corporation (NYSEMKT:CVM)
DARA Biosciences Inc (NASDAQ:DARA) opened the session at $0.76, trading in a range of $0.71 - $0.76. The stock showed a negative performance of -5.26% in the last trading session from its previous close of $0.76 and closed at $0.720. The stock traded on a volume of 1.18 million shares and the average volume of the stock remained 1.64 million shares. DARA BioSciences, Inc. is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. The Company has the exclusive United States marketing rights to its Soltamox (oral liquid tamoxifen).
Has DARA Found The Bottom and Ready To Move Up? Find Out Here
Castle Brands Inc (NYSEMKT:ROX) traded 1.11 million shares in the last business day while the average volume of the stock remained 569,294 shares. The stock showed a negative movement of -5.00% to end at $0.815. The 52 week range of the stock remained $0.25- $1.10. Castle Brands Inc. develops and markets beverage alcohol categories. Its beverage alcohol categories includes rum, whiskey, liqueurs, vodka and tequila. It distributes its products in all 50 states in the United States and the District of Columbia, in thirteen primary international markets, including Ireland, Great Britain, Northern Ireland, Germany, Canada, South Africa, Bulgaria, France, Russia, Finland, Norway, Sweden, China and the Duty Free markets, and in a number of other countries in continental Europe and Latin America.
Has ROX Found The Bottom And Ready To Gain Momentum? Find Out Here
DURECT Corporation (NASDAQ:DRRX) reported 1.45 million shares were exchanged during the last trade, while the average volume is about 968,293 shares. The stock dropped -5.07% and finished the day at $2.06. The beta of the stock is recorded at 1.55. Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New Drug Application (NDA) with the United States Food and Drug Administration (FDA), with one program in Phase III with an NDA in preparation, two programs in Phase II and three programs in Phase I.
Why Should Investors Buy DRRX After the Recent Fall? Just Go Here and Find Out
CEL-SCI Corporation (NYSEMKT:CVM) shares dropped -4.95 percent from its previous close of $0.91 to close at $0.865. Traded with volume of 1.57 million shares in the prior session and the average volume of the stock remained 1.47 million shares. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Will CVM Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)